share_log

Agape ATP | 8-K: Current report

SEC ·  Nov 29, 2024 22:04

Summary by Moomoo AI

Agape ATP Corporation entered into MOUs with three Indonesian healthcare institutions on November 25, 2024, to collaborate on enhancing research capabilities, fostering medical innovations, and conducting clinical studies on the company's health products. The partnerships involve Dr. Sardjito General Hospital in Yogyakarta, Dr. H. A. Rotinsulu Lung Hospital in Bandung, and Dr. M. Goenawan Partowidigdo Respiratory Hospital in Bogor.The initiative aims to advance medical research, introduce innovative treatment strategies, and strengthen training programs to address respiratory diseases such as tuberculosis and chronic obstructive pulmonary disease. These collaborations will ensure Agape ATP's products comply with Indonesian health standards and meet regulatory requirements prior to market distribution. The partnerships also focus on integrating sustainable medical innovations and aligning with the United...Show More
Agape ATP Corporation entered into MOUs with three Indonesian healthcare institutions on November 25, 2024, to collaborate on enhancing research capabilities, fostering medical innovations, and conducting clinical studies on the company's health products. The partnerships involve Dr. Sardjito General Hospital in Yogyakarta, Dr. H. A. Rotinsulu Lung Hospital in Bandung, and Dr. M. Goenawan Partowidigdo Respiratory Hospital in Bogor.The initiative aims to advance medical research, introduce innovative treatment strategies, and strengthen training programs to address respiratory diseases such as tuberculosis and chronic obstructive pulmonary disease. These collaborations will ensure Agape ATP's products comply with Indonesian health standards and meet regulatory requirements prior to market distribution. The partnerships also focus on integrating sustainable medical innovations and aligning with the United Nations Sustainable Development Goals.The MOU signings mark a key milestone in Agape ATP's strategic expansion plans in Indonesia and Southeast Asia. The company's Founder and Global Group CEO, Prof. Dato' Sri Dr. How Kok Choong, emphasized the importance of these partnerships in addressing major public health concerns and leveraging global expertise to advance healthcare innovation in the region.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more